Suppr超能文献

有效吡格列酮治疗超重猴子的体液隔室转移:对过氧化物酶体增殖物激活受体-γ激动剂在糖尿病前期应用的影响。

Fluid compartmental shifts with efficacious pioglitazone therapy in overweight monkeys: implications for peroxisome proliferator-activated receptor-gamma agonist use in prediabetes.

机构信息

Department of Pathology, Section on Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27127, USA.

出版信息

Metabolism. 2010 Jun;59(6):914-20. doi: 10.1016/j.metabol.2010.02.010. Epub 2010 Mar 2.

Abstract

Pioglitazone is prescribed to improve insulin sensitivity in type 2 diabetes mellitus patients and has been discussed as a therapy for metabolic syndrome. Pioglitazone and other thiazolidinediones are associated with fluid retention and edema that may exacerbate existing or developing congestive heart failure, which is often present in these patients. Using a nonhuman primate model, our aims were to evaluate (1) whether fluid shifts were detectable in normoglycemic monkeys, (2) which fluid compartment changed, and (3) whether fluid retention was dose dependent. Seventeen adult male cynomolgus macaques (Macaca fascicularis) were studied in a Latin square design such that all animals received 0, 1, 2, and 5 mg/kg pioglitazone for 6 weeks with 2 weeks of washout between dosing intervals. Doses approximated human exposures achieved with 30, 45, and 60 mg. At the end of each period, animals were weighed and underwent dual-absorption x-ray absorption scanning for body composition measurements. Fluid volumes were quantitated by Evans blue dilution for plasma volume, equilibration of sodium bromide for extracellular water, and deuterated water for total body water. Significant (P < .05) effects were seen with expansion of PV at both the 2- and 5-mg/kg doses, along with reduced plasma sodium at 5 mg/kg; however, surrogate end points used to indicate fluid retention (body weight, hematocrit, total protein, and albumin) did not change significantly. Significant trends toward increases in interstitial fluid and extracellular water with increasing dose were apparent. Pioglitazone effectively improved metabolic status by significantly decreasing fasting glucose and triglycerides and increasing adiponectin. We conclude that thiazolidinedione-related plasma volume expansion occurs in nondiabetic primates and that fluid retention is detectable when compartments are directly measured.

摘要

吡格列酮被用于改善 2 型糖尿病患者的胰岛素敏感性,并被讨论作为治疗代谢综合征的一种方法。吡格列酮和其他噻唑烷二酮类药物与液体潴留和水肿有关,这可能会使这些患者中已经存在或正在发展的充血性心力衰竭恶化。我们使用非人类灵长类动物模型,旨在评估:(1)在血糖正常的猴子中是否可以检测到液体转移;(2)哪个液体隔室发生变化;(3)液体潴留是否与剂量有关。17 只成年雄性食蟹猴(Macaca fascicularis)按照拉丁方设计进行研究,所有动物均接受 0、1、2 和 5mg/kg 吡格列酮治疗 6 周,给药间隔之间有 2 周洗脱期。剂量与 30、45 和 60mg 时人类的暴露量近似。在每个时期结束时,对动物进行称重,并进行双吸收 X 射线吸收扫描以进行身体成分测量。通过 Evans 蓝稀释测量血浆容量、溴化钠平衡测量细胞外液以及氘化水测量全身水来定量液体量。在 2 和 5mg/kg 剂量下均观察到 PV 扩张(P<0.05),同时在 5mg/kg 时观察到血浆钠降低;然而,用于指示液体潴留的替代终点(体重、红细胞压积、总蛋白和白蛋白)没有明显变化。随着剂量的增加,间质液和细胞外液增加的明显趋势。吡格列酮通过显著降低空腹血糖和甘油三酯以及增加脂联素显著改善了代谢状态。我们得出结论,噻唑烷二酮类相关的血浆容量扩张发生在非糖尿病灵长类动物中,并且当直接测量隔室时可以检测到液体潴留。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验